Compare Stocks: RCEL, CNMD, DRTS, and IART

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
CNMD CONMED	$46.34 +0.9%	$48.04	$31.44 ▼ $53.66	$1.38B	0.94	323,426 shs	240,738 shs
DRTS Alpha Tau Medical	$14.77 +1.8%	$14.17	$3.43 ▼ $15.79	$1.31B	1.22	480,751 shs	307,125 shs
IART Integra LifeSciences	$12.68 -21.2%	$16.69	$8.70 ▼ $20.49	$1.25B	1.21	884,975 shs	2.69 million shs
RCEL Avita Medical	$12.72 +5.9%	$9.26	$3.22 ▼ $12.76	$369.63M	1.98	286,326 shs	391,166 shs

The 7 Hottest IPO Stories of 2026

MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
CNMD CONMED	+1.04%	+2.06%	-6.55%	+37.13%	-1.75%
DRTS Alpha Tau Medical	+1.79%	+1.58%	+3.07%	+11.64%	+237.99%
IART Integra LifeSciences	-21.19%	-21.34%	-24.57%	-29.75%	-13.92%
RCEL Avita Medical	+5.91%	+7.43%	+18.22%	+151.38%	+142.29%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
CNMD CONMED	$46.34 +0.9%	$48.04	$31.44 ▼ $53.66	$1.38B	0.94	323,426 shs	240,738 shs
DRTS Alpha Tau Medical	$14.77 +1.8%	$14.17	$3.43 ▼ $15.79	$1.31B	1.22	480,751 shs	307,125 shs
IART Integra LifeSciences	$12.68 -21.2%	$16.69	$8.70 ▼ $20.49	$1.25B	1.21	884,975 shs	2.69 million shs
RCEL Avita Medical	$12.72 +5.9%	$9.26	$3.22 ▼ $12.76	$369.63M	1.98	286,326 shs	391,166 shs

The 7 Hottest IPO Stories of 2026

MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
CNMD CONMED	+1.04%	+2.06%	-6.55%	+37.13%	-1.75%
DRTS Alpha Tau Medical	+1.79%	+1.58%	+3.07%	+11.64%	+237.99%
IART Integra LifeSciences	-21.19%	-21.34%	-24.57%	-29.75%	-13.92%
RCEL Avita Medical	+5.91%	+7.43%	+18.22%	+151.38%	+142.29%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
CNMD CONMED	1.88	Reduce	$41.40	-10.67% Downside
DRTS Alpha Tau Medical	2.38	Hold	$15.40	4.27% Upside
IART Integra LifeSciences	1.88	Reduce	$18.86	48.72% Upside
RCEL Avita Medical	2.57	Moderate Buy	$11.40	-10.38% Downside

Current Analyst Ratings Breakdown

Latest RCEL, CNMD, DRTS, and IART Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
10/1/2026	IART Integra LifeSciences	Truist Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Hold
9/21/2026	RCEL Avita Medical	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (E+)
9/17/2026	CNMD CONMED	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Sell (D+) ➝ Hold (C-)
9/3/2026	DRTS Alpha Tau Medical	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Overweight	$17.00 ➝ $30.00
9/1/2026	DRTS Alpha Tau Medical	Zacks Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Hold ➝ Strong Sell
8/28/2026	RCEL Avita Medical	Lake Street Capital Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Buy	$8.00 ➝ $12.00
8/19/2026	RCEL Avita Medical	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Buy	$12.00 ➝ $14.00
8/19/2026	RCEL Avita Medical	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Buy	$7.00 ➝ $11.00
8/14/2026	IART Integra LifeSciences	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Sell (E+) ➝ Sell (D-)
8/11/2026	CNMD CONMED	Zacks Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Strong Sell ➝ Hold
8/11/2026	DRTS Alpha Tau Medical	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Buy	$15.00 ➝ $16.00

(Data available from 10/2/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
CNMD CONMED	$1.37B	1.01	$7.26 per share	6.38	$33.36 per share	1.39
DRTS Alpha Tau Medical	N/A	N/A	N/A	N/A	$0.88 per share	N/A
IART Integra LifeSciences	$1.64B	0.60	$3.33 per share	3.81	$13.40 per share	0.95
RCEL Avita Medical	$71.61M	5.47	N/A	N/A	($0.55) per share	-23.13

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
CNMD CONMED	$47.06M	$1.85	25.05	9.80	2.09	4.12%	14.31%	6.33%	10/28/2026 (Confirmed)
DRTS Alpha Tau Medical	-$42.63M	-$1.04	N/A	N/A	N/A	N/A	-138.12%	-81.68%	11/19/2026 (Estimated)
IART Integra LifeSciences	-$516.47M	-$0.09	N/A	4.93	0.83	-0.44%	18.30%	5.30%	10/29/2026 (Estimated)
RCEL Avita Medical	-$48.59M	-$1.44	N/A	N/A	N/A	-56.96%	N/A	-78.53%	11/5/2026 (Estimated)

Latest RCEL, CNMD, DRTS, and IART Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
10/29/2026	Q3 2026	IART Integra LifeSciences	$0.56	N/A	N/A	N/A	$416.30 million	N/A
10/28/2026	Q3 2026	CNMD CONMED	$1.00	N/A	N/A	N/A	$336.25 million	N/A
8/10/2026	Q2 2026	DRTS Alpha Tau Medical	-$0.1409	-$0.50	-$0.3591	-$0.50	$0.14 million	N/A
8/6/2026	Q2 2026	RCEL Avita Medical	-$0.2928	-$0.25	+$0.0428	-$5.00	$20.25 million	$21.70 million
7/29/2026	Q2 2026	CNMD CONMED	$1.11	$1.38	+$0.27	$0.77	$337.60 million	$343.49 million
7/29/2026	Q2 2026	IART Integra LifeSciences	$0.4805	$0.56	+$0.0795	$0.06	$417.54 million	$418.76 million

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
CNMD CONMED	N/A	N/A	-5.59%	N/A	N/A
DRTS Alpha Tau Medical	N/A	N/A	N/A	N/A	N/A
IART Integra LifeSciences	N/A	N/A	N/A	N/A	N/A
RCEL Avita Medical	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
CNMD CONMED	0.63	1.48	0.69
DRTS Alpha Tau Medical	0.15	11.09	7.79
IART Integra LifeSciences	1.75	3.60	2.11
RCEL Avita Medical	N/A	0.41	0.34

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
CNMD CONMED	N/A
DRTS Alpha Tau Medical	2.65%
IART Integra LifeSciences	84.78%
RCEL Avita Medical	27.66%

Insider Ownership

Company	Insider Ownership
CNMD CONMED	0.28%
DRTS Alpha Tau Medical	39.50%
IART Integra LifeSciences	3.84%
RCEL Avita Medical	2.24%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
CNMD CONMED	3,900	29.95 million	29.87 million	Optionable
DRTS Alpha Tau Medical	121	90.33 million	54.65 million	No Data
IART Integra LifeSciences	4,427	77.77 million	74.79 million	Optionable
RCEL Avita Medical	226	30.78 million	30.09 million	Optionable

RCEL, CNMD, DRTS, and IART Headlines

Recent News About These Companies

Is AVITA Medical Inc (RCEL) Overvalued After 5.9% Rally? GF Value Says Overvalued

1 hour ago | gurufocus.com

AVITA Medical (RCEL) Stock Sees Fair Value Lift After PermeaDerm Data And Q2 Beat

October 1 at 7:46 PM | finance.yahoo.com

NewEdge Advisors LLC Purchases 62,046 Shares of Avita Medical Inc. $RCEL

September 25, 2026 | defenseworld.netD

AVITA Medical, Inc. (RCEL) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript

September 16, 2026 | seekingalpha.com

AVITA Medical consensus price target increased by 12.12% to $12.58

September 15, 2026 | msn.com

Avita Medical Inc. (NASDAQ:RCEL) Receives Consensus Recommendation of "Moderate Buy" from Brokerages

September 13, 2026 | marketbeat.com

564,952 Shares in Avita Medical Inc. $RCEL Bought by BlackRock Inc.

September 6, 2026 | marketbeat.com

RCEL stock gains on fresh price data while Avita Medical readies next steps

September 5, 2026 | ad-hoc-news.deA

AVITA Medical to Participate in Lake Street Best Ideas Growth Conference and Morgan Stanley Healthcare Conference

September 2, 2026 | globenewswire.com

All You Need to Know About Avita Medical (RCEL) Rating Upgrade to Buy

August 31, 2026 | zacks.com

Avita Medical Inc. (RCEL) is a Great Momentum Stock: Should You Buy?

August 24, 2026 | zacks.com

AVITA Medical: Favorable Reimbursements For Skin Wound Care

August 24, 2026 | seekingalpha.com

AVITA Medical (NASDAQ:RCEL) Raises Full-Year Guidance on Spray-On Skin Adoption

August 19, 2026 | kalkinemedia.comK

Avita Medical Says PermeaDerm Study Meets Primary Endpoint, Showing 70% Cost Reduction

August 18, 2026 | finance.yahoo.com

AVITA rises as wound care product succeeds in US burn center trial

August 18, 2026 | msn.com

AVITA Medical Announces Positive PermeaDerm® Study Results Demonstrating 70% Economic Advantage over Allograft and Comparable Clinical Outcomes

August 18, 2026 | globenewswire.com

AVITA Medical (RCEL) Q2 2026 Earnings Call Transcript

August 13, 2026 | finance.yahoo.com

AVITA Medical to Host Investor Webinar Briefing

August 9, 2026 | globenewswire.com

AVITA Medical Reports Second Quarter Results, Raises 2026 Revenue Guidance, and Expects Fourth Quarter Cash Flow Breakeven

August 7, 2026 | markets.businessinsider.com

Avita Medical shares surge after record second-quarter performance

August 7, 2026 | msn.com

AVITA Medical Announces Participation at Canaccord Genuity Growth Conference

August 7, 2026 | globenewswire.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

RCEL, CNMD, DRTS, and IART Company Descriptions

CONMED NYSE:CNMD

$46.34 +0.41 (+0.90%)

Closing price 10/2/2026 03:59 PM Eastern

Extended Trading

$46.35 +0.01 (+0.02%)

As of 10/2/2026 07:30 PM Eastern

CONMED Corporation, a medical technology company, develops, manufactures, and sells surgical devices and related equipment for surgical procedures worldwide. The company offers orthopedic surgery products, including BioBrace, TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and Agro Knotless Suture Anchors, which provide clinical solutions to orthopedic surgeons for the augmentation and repair of soft tissue injuries, as well as provides supporting products that enable surgeons to perform minimally invasive sports medicine surgeries. It markets orthopedic surgery products under the Hall, CONMED Linvatec, Concept, and Shutt brands. The company also provides battery-powered and autoclavable bone power tool systems for use in orthopedic, arthroscopic, oral/maxillofacial, podiatric, spinal, and cardiothoracic surgeries under Hall surgical brand name. In addition, it offers general surgery products, including clinical insufflation systems under AirSeal brand; smoke removal devices under Buffalo Filter brand; endomechanical products, such as tissue retrieval bags, trocars, suction irrigation devices, graspers, scissors, and dissectors used in minimally invasive surgeries; and electrosurgical solution comprising monopolar and bipolar generators, argon beam coagulation generators, handpieces, smoke management systems and other accessories. Further, the company provides endoscopic technologies, including therapeutic and diagnostic products for use in gastroenterology procedures, and products for the treatment of diseases of the dilatation, hemostasis, biliary, structure management, and infection prevention and patient monitoring, including ECG and EEG electrodes, and cardiac defibrillation pads. It markets its products directly to hospitals, surgery centers, and other healthcare institutions, as well as through medical specialty distributors. CONMED Corporation was incorporated in 1970 and is headquartered in Largo, Florida.

Alpha Tau Medical NASDAQ:DRTS

$14.77 +0.26 (+1.79%)

Closing price 10/2/2026 04:00 PM Eastern

Extended Trading

$14.73 -0.04 (-0.30%)

As of 10/2/2026 07:57 PM Eastern

Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, engages in research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer In Israel and the United States. Its Alpha-DaRT technology used in clinical trials for skin, oral, pancreatic, prostate, and breast cancers; and preclinical studies for brain, hepatic cell carcinoma, glioblastoma multiforme, lung cancer, and others. The company was incorporated in 2015 and is headquartered in Jerusalem, Israel.

Integra LifeSciences NASDAQ:IART

$12.68 -3.41 (-21.19%)

Closing price 10/2/2026 04:00 PM Eastern

Extended Trading

$12.85 +0.17 (+1.33%)

As of 10/2/2026 07:56 PM Eastern

Integra LifeSciences Holdings Corporation manufactures and sells surgical instruments, neurosurgical products, and wound care products for use in neurosurgery, neurocritical care, and otolaryngology. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment; and surgical headlamps and instrumentation, as well as after-market services. It also sells instrument patterns, and surgical and lighting products to hospitals and surgery centers, as well as dental, podiatry, and veterinary offices. In addition, the company provides regenerative technology products for the treatment of acute wounds; and surgical tissue repair products for hernia, tendon, peripheral nerve repair and protection. Further, it offers skin and wound repair, plastics and surgical reconstruction products, bone grafts, and nerve and tendon repair products. The company offers its products directly through various sales forces and other distribution channels to the hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers, and health care providers in the United States, Europe, Asia Pacific, and internationally. Integra LifeSciences Holdings Corporation was incorporated in 1989 and is headquartered in Princeton, New Jersey.

Avita Medical NASDAQ:RCEL

$12.72 +0.71 (+5.91%)

Closing price 10/2/2026 04:00 PM Eastern

Extended Trading

$12.72 -0.01 (-0.04%)

As of 10/2/2026 07:30 PM Eastern

AVITA Medical, Inc., together with its subsidiaries, operates as a regenerative medicine company in the United States and internationally. The company's lead product is the RECELL System, a cell harvesting device used for the treatment of thermal burn wounds, full-thickness skin defects, and repigmentation of stable depigmented vitiligo lesions. It develops RECELL GO to control the manual process of disaggregation, filtration, and soak time. The company was formerly known as AVITA Therapeutics, Inc. AVITA Medical, Inc. was incorporated in 2020 and is headquartered in Valencia, California.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest RCEL, CNMD, DRTS, and IART Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest RCEL, CNMD, DRTS, and IART Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

RCEL, CNMD, DRTS, and IART Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

RCEL, CNMD, DRTS, and IART Company Descriptions

CONMED NYSE:CNMD

Alpha Tau Medical NASDAQ:DRTS

Integra LifeSciences NASDAQ:IART

Avita Medical NASDAQ:RCEL

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest RCEL, CNMD, DRTS, and IART Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest RCEL, CNMD, DRTS, and IART Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

RCEL, CNMD, DRTS, and IART Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

RCEL, CNMD, DRTS, and IART Company Descriptions

CONMED NYSE:CNMD

Alpha Tau Medical NASDAQ:DRTS

Integra LifeSciences NASDAQ:IART

Avita Medical NASDAQ:RCEL

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools